The effects of crocin, insulin and their co-administration on the heart function and pathology in streptozotocin-induced diabetic rats

Document Type : Original Research Article

Authors

1 Division of Pathology, Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

2 Division of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

Abstract


Objective: Crocinisa saffron constituent with a potent anti-oxidant activity. The present study investigated the effects of crocin and insulin treatments (alone or in combination) on cardiac function and pathology in diabetic rats.

Materials and Methods: Diabetes was induced by intraperitoneal (i.p.) injection of streptozotocin (STZ, 50 mg/kg). Thereafter, crocin (5, 10 and 20 mg/kg, i.p.), subcutaneous (s.c.) injection of insulin (4 IU/kg) and their combination were administeredfor eight weeks. Blood glucose level andwhole heart and body weights were measured. Electrocardiography (ECG) was carried out using the lead II. Serum concentrations of lactate dehydrogenase (LDH), creatine kinase-MB isoenzyme (CK-MB), and the heart tissue malodialdehyde (MDA) and superoxide dismutase (SOD) contents were determined. The heart lesions were evaluated by light microscopy.

Results: STZ decreased body weight and increased whole heart weight/body weight ratio. It also decreased heart rate, and increased RR and QT intervals and T wave amplitude. STZ increased blood glucose, serum LDH andCK-MB levels, augmentedheart tissue MDA content, decreased SOD content of heart tissue, and produced hemorrhages, degeneration, interstitial edema, and fibroblastic proliferation in the heart tissue. Crocin (10 and 20 mg/kg, i.p.), insulin (4 IU/kg, s.c.) and their combination (5 mg/kg of crocin with 4 IU/kg of insulin) treatments recovered the ECG, biochemical and histopathological changes induced by STZ.

Conclusion: The results showed cardioprotective  effects of crocin and insulin in STZ-induced diabetic rats. The antioxidant and anti-hyperglycemic properties of crocin and insulin may be involved in their cardioprotective actions.

Keywords

Main Subjects

References

Adegate E, Kalasz H, Veress G, Teke K. 2010. Medicinal chemistry of drugs used in diabetic cardiomyopathy. Curr Med Chem, 17: 517-551.
Akhtar MS, Pillai KK, Hassan Q, Ansari SH, Ali J, Akhtar M. 2016.Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy. Clin Exp Hypertens, 38: 10-22.
Al-Rasheed NM, Al-Rasheed NM, Attia HA, Hasan IH, Al-Amin M, Al-Ajmin H, Mohamad RA. 2013. Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms? J Physiol Biochem, 69: 671-678.
Altinoz E, Oner Z, Elbe H, Ciqremis Y, Turkoz Y. 2015. Protective effects of saffron (its active constituent, crocin) on nephropathy in stereptozotocin-induced diabetic rats. Human ExpToxicol, 34: 127-134.
Asri-Rezaei S, Tamaddonfard E, Ghasemsoltani-Momtaz B, Erfanparast A, Gholamalipour S. 2015. Effects of crocin and zinc chloride on blood levels of zinc and metabolic and oxidative parameters in streptozotocin-induced diabetic rats. Avicenna J Phythomed, 5: 403-412.
Boussabbeh M, Ben Salem I, Neffati F, Najjar MF, Bacha H, Abid-Essefi S. 2015. Crocin prevents patulin-induced acute toxicity in cardiac tissues via the regulation of oxidative damage and apoptosis. J Biochem Mol Toxicol, 10.1002/gbt.21718.
Delides A, Spooner RJ, Goldberg DM, Neal FE. 1976. An optimized semi-automatic rate method for serum glutathione reductase activity and its application to patients with malignant disease. J Clin Pathol, 29: 73-77.
Dianat M, Esmaeilizadeh M, Badavi M, Samarbafzadeh AR, Naghizadeh B. 2014a. Protective effects of crocin on ischemia-reperfusion induced oxidative stress in comparison with vitamin E in isolated rat hearts. Jundishapur J Nat Pharm Prod, 9: e17187.
Dianat M, Esmaeilizadeh M, Badavi M, Samarbafzadeh AR, Naghizadeh B. 2014b. Protective effects of crocin on hemodynamic parameters and infarct size in comparison with vitamin E after ischemia reperfusion in isolated rat hearts. Planta Med, 80: 393-398.
Erken HA, Genc O, Erken G, Ayada C, Gundagdu G, Dogan H. 2015. Ozone partially prevents diabetic neuropathy in rats. Exp Clin Endocrinol Diabetes, 123: 101-105.
Esmaeilizadeh M, Dianat M, Badavi M, Samarbafzadeh A, Naghizadeh B. 2015. Effect of crocin on nitric oxide synthase expression in post-ischemic isolated rat heart. Avicenna J Phytomed, 5: 420-426.
Farshid AA, Tamaddonfard E. 2015. Histopathological and behavioral evaluations of the effects of crocin, safranal and insulin on diabetic peripheral neuropathy in rats. Avicenna J Phytomed, 5: 469-478.
Farshid AA, Tamaddonfard E, Simaee N, Mansouri S, Najafi S, Asri-Rezaee S, Alavi H. 2014. Effects of histidine and N-acetylcysteine on doxorubicin-induced cardiomyopathy in rats. Cardiovasc Toxicol, 14: 153-161.
Forouhi NG, Wareham NJ.  2014. Epidemiology of diabetes. Medicine (Abingdon), 42: 698-702.
Futterman LG, Lemberg L. 1997. SGOT, LDH, HBD, CPK, CK-MB, MB1MB2, cTnT, cTnC, cTnT. Am J Crit Care, 6: 333-338.
Gao Y, Kang L, Li C, Wang X, Sun C, Li Q, Liu R, Wang J. 2016. Resveratrol ameliorates diabetes-induced cardiac dysfunction through AT1R-EEK/p38 MAPK signaling pathway. Cardiovasc Toxicol, 16: 130-137.
Gonda S, Parizsa P, Suranyi G, Cyemant G, &Vasas G. 2012. Quantification of main bioactive metabolites from saffron (Crocus sativus) stigmas by a micellar electrokinetic chromatographic (MEKC) method. J Pharm Biomed Anal, 66: 68-74.
Goyal SN, Arora S, Sharma AK, Joshi S, Ray R, Bhatia J, Kumari S, Arya DS. 2010. Protective effect of crocin of Crocus sativus on hemodynamics, biochemical, histological and ultrastrutural alternations in isopeoteronol-induced cardiotoxicity in rats. Phytomedicine, 17: 227-232.
Howarth FC, Jacobson M, Shafiullah M, Adeghate E. 2005. Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol, 90: 827-835.
Howarth FC, Adeghate E, Jacobson M. 2009a. Heart rate and QT interval in streptozotocin-induced diabetic rats. J Med Sci, 2: 108-118.
Howarth FC, Jacobson M, Qureshi MA, Shafiullah M, Hameed RS, Zilahi E, Al Haj A, Nowotny N, Adeghate E. 2009b. Altered gene expression may underlie prolonged duration of the QT interval and ventricular action potential in streptozotocin-induced diabetic rat heart. Mol Cell Biochem, 328: 57-65.
Jankyova S, Kmecova J, Cernecka H, Mesarosova L, Musil P, Brnoliakova Z, Kyselovic J, Babal P, Klimas J. 2012. Glucose and blood pressure lowering effects of Pyenogenol are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy. Pathol Res Pract, 208: 452-457.
Ji L, Fu F, Zhang L, Liu W, Cai X, Zhang L, Zheng Q, zhang H, Gao F.  2010. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol and Metab, 298: 668-674.
Kavak S, Ayaz L, Emre M. 2012. Effects of rosiglitazone with insulin combination therapy on oxidative stress and lipid profile in left ventricular muscles of diabetic rats. Exp Diabetes Res, 2012: 905683.
Khullar M, Al-Shudiefat AA, Ludke A, Binepal G, Singal PK. 2010. Oxidative stress: a key contributor to diabetic cardiomyopathy. Can J Physiol Pharmacol, 88: 233-240.
Kim BO, Verma S, Weisel RD, Fazel S, Jia ZQ, Mizuno T, Li PK. 2008. Preservation of heart function in diabetic rats by combined effects of muscle cell implantation and insulin therapy. Eur J Heart Fail, 10: 14-21.
Kmecova J, Klimas J. 2010. Heart rate correction of the QT duration in rats. Eur J Pharmacol, 641: 187-192.
Kuo WW, Chung LC, Liu CT, Wu SP, Kuo CH, Tsai FJ, Lu MC, Huang CY, Lee SD. 2009. Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats. Cell Biochem Funct, 27: 479-487.
Letonja M, Petrovic DP. 2014. Is diabetic cardiomyopathy a specific entity? World J Cardiol, 26: 8-13.
Lengyel C, Virag L, Biro T, Jost N, Magyar J, Biliczki P, Kocsis E, Skoumal R, Nanasi PP, Toth M, Kecskemeti V, Papp JG, Varro A. 2007. Diabetes mellitus attenuates the repolarization reserve in mammalian heart. Cardiovasc Res, 73: 512-520.
Lin YC, Huang J, Kan H, Castranova V, Frisbee JC, Yu HG. 2012. Defective calcium inactivation causes long QT in obsess insulin-resistant rat. Am J Physiol Heart CircPhysiol, 302: H1013-H1022.
Liu H, Chen YF, Li F, Zhang HY. 2013. Fructus Gardenia (Gardenia jasminoides J. Ellis) phytochemistry, pharmacology of cardiovascular and safety with the perspective of new drugs development. J Asian Nat Prod Res, 15: 94-110.
Liu Q, Wang S, Cai L. 2014. Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J Diabetes Invest, 5: 623-634.
Lowry OH, Rossenbrough NJ, Farr AL, Randall KJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem, 193: 265-275.
Ng CS, Lee JV, Toh MP, Ko Y. 2014. Cost-of-illness studies of diabetes mellitus: a systematic   review. Diabetes Res Clin Pract, 105: 151-163.
Ohkawa H, Ohishi N, Yagi K. 1979 Assay of lipid peroxidase in normal tissue by thiobarbituric acid reaction. Anal Biochem, 95: 351-358.
Postema PG, Wilde AA. 2014. The measurement of the QT interval. Curr Cardiol Rev, 10: 287-294.
Rahaiee S, Moini S, Hashemi M, Shojaosadati SA. 2015. Evaluation of antioxidant activities of bioactive compounds and various extracts obtained from saffron (Crocus sativus L.): a review. J Food Sci Technol, 52: 1881-1888.
Rajaei Z, Hadjizadeh MA, Namati H, Hosseini M, Ahmadi M, Shafiee S. 2013. Antihyperglycemic and antioxidant activity of crocininstreptozotocin-induced diabetic rats. J Med Food, 16: 206-210.
Razavi BM, Hosseinzadeh H, Movassaghi AR, Imenshahidi M, Abnous K. 2013. Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure. Chem Biol Interact, 203: 547-555.
Semaming Y, Kumfu S, Pannangpetch P, Chattipakorn SC, Chattipakorn N. 2014. Protocatechuic acid exerts a cardioprotective effect in type 1 diabetic rats. J Endocrinol, 233: 13-23.
Shawm JE, Sicree RA, Zimmet PZ. 2010. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 87: 4-14.
Shirali S, Zahra Bathaie S, Nakhjavani M. 2013. Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats.Phytother Res, 27: 1042-1047. 13
Simova I, Christov I, Bortolan G. 2015. A review on electrocardiographic changes in diabetic patients.Curr Diabetes Rev, 11: 102-106.
Stadler K. 2012. Oxidative stress in diabetes.Adv Exp Med Biol, 771: 272-287.
Szkudelski T. 2001. The mechanisms of alloxan and streptozotocin action in B cells of the rat pancreas.Physiol Res, 50: 536-546.
Tamaddonfard E, Farshid AA, Asri-Rezaee S, Javadi S, Khosravi V, Rahman B, Mirfakhraee Z. 2013. Crocin improved learning and memory impairments in streptozotocin-induced diabetic rats. Iran J Basic Med Sci, 16: 91-100.
VanHoose L, Sawers Y, Loganathan R, Vacek JL, Stehno-Bittel L, Norikova L, Al-Jarrah M, Smirnova IV. 2010. Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat. Cardiovasc Diabetol, 9: 56.
Wang G, Li W, Lu X, Bao P, Zhao X. 2012. Luteolin ameliorates cardiac failure in type 1 diabetic cardiomyopathy. J Diabetes Complications, 26: 259-265.
Wang GG, Li W, Lu XH, Zhao X, Xu L. 2013. Taurine attenuates oxidative stress and alleviates cardiac failure in type 1 diabetic rats. Croat Med J, 54: 171-179.
Wang K, Zhang L, Rao W, Su N, Hui H, Wang L, Peng G, Tu Y, Zhang S, Fei Z. 2015. Neuroprotective effects of crocin against traumatic brain injury in mice: involvement of notch signaling pathway. Neurosci Lett, 591: 53-58.
Warne JP, Horneman HF, Wick EC, Bhargava A, Pecoraro NC, Ginsberg AB, Akana SE, Dallman MF. 2005. Comparison of superior mesenteric versus jugular venous infusions of insulin in streptozotocin-diabetic rats on the choice of caloric intake, body weight and fat stores. Endocrinology, 147: 5443-5451.
Wayhs CA, Tortato C, Mescka CP, Pasquali MA, Schnorr CE, Nin MS, Barros HM, Moreira JC, Vargas CR. 2013. The association effect of insulin and clonazepam on oxidative stress in liver of an experimental animal model of diabetes and depression. Pharm Biol, 51: 533-538.
Wu Z, Chen Q, Ke D, Li G, Deng W. 2014. Emodin protects against diabetic cardiomyopathy by regulating the AKT/GSK-3β signaling pathway in the rat model. Molecules, 19: 14782-14793.
Zobali F, Avci A, Canbolat O, Karasu C. 2002. Effects of vitamin A and insulin on the antioxidant state of diabetic rat heart: a comparison study with combination treatment. Cell Biochem Funct, 20: 75-80.
Zhang Z, Wang CZ, Wen XD, Shoyama Y, Yuan CS. 2013.Role of saffron and its constituents on cancer chemoprevention. Pharm Biol, 51: 920-924.
Zheng H, Pu SY, Fan XF, Li XS, Zhang Y, Yuan J, Zhang YF, Yang JL. 2015. Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats. Biochem Pharmacol, 95: 38-45.
.
 
 
 
Avicenna Journal of Phytomedicine
Volume 6, Issue 6 - Serial Number 6
November and December 2016
Pages 658-670

Files

Share

How to cite

Statistics